The Ohio State University Wexner Medical Center Clinical Laboratories

Columbus, Ohio 43221

3 studies enrolling now · 4 studies all time

What they study most

Locally Advanced Basal Cell Carcinoma, Locally Advanced Cutaneous Squamous Cell Carcinoma, PD-L1 Positive, Triple Negative Breast Cancer

Studies at this site

• L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) — Recruiting now
• L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma — Recruiting now
• L19IL2/TNF in Patients With Basal Cell Carcinoma — Recruiting now
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling